VAERS Reports G13275

VAERS 2517398

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge G13275

moderat

Staat: CA
Alter: 76,0
Geschlecht: F
Eingang: 26.11.2022
Impfdatum: 01.11.2022
Beginn: 05.11.2022
Tage bis Beginn: 4,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Atrial fibrillation Brain natriuretic peptide normal Chest pain Condition aggravated Fatigue Feeling abnormal Fibrin D dimer Troponin normal

Symptomtext

Chest pain and Atrial Fibrillation, not heart attack per lab tests, after two weeks of extreme fatigue, finally back to feeling normal.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: D-Dimer = 0.64 11/07/2022 Troponin I = <0.02 11/07/2022 BNP = 84 11/07/2022
Aktuelle Erkrankungen: none
Vorgeschichte: Atrial fibrillation
Andere Medikamente: Losartan, Eliquis, Atorvastatin, Dofetilide
Allergien: none
Vorherige Impfungen: chest pain, Atrial Fibrillation, 75 years, 10/08/2021 Covid Pfizer mRNA LNP-S PF

VAERS 2562929

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge G13275

gering

Staat: PA
Alter: 54,0
Geschlecht: M
Eingang: 19.01.2023
Impfdatum: 28.10.2022
Beginn: -
Tage bis Beginn: -
Dosis: 4
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Drug ineffective SARS-CoV-2 test

Symptomtext

Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 54-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 28Oct2022 at 12:00 as dose 4 (booster), single (Lot number: G13275) at the age of 54 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Past drug history included: Doxycycline, reaction(s): "Known allergies", notes: Known allergies: doxycycline. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Positive, notes: Treatment of COVID-19; (12Jan2023) Positive, notes: Returned to testing positive for COVID four days after completing Paxlovid treatment. Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: No other medication in 2 weeks. Received anti-viral treatment for COVID 19 from 03Jan2023 to 08Jan2023. Returned to testing positive for COVID four days after completing Paxlovid treatment.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: Test Name: Covid-19; Test Result: Positive ; Comments: Treatment of COVID-19; Test Date: 20230112; Test Name: Covid-19; Test Result: Positive ; Comments: Returned to testing positive for COVID four days after completing Paxlovid treatment.
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None, Comment: Other medical history: no
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -